Surgery Partners Inc (SGRY)

$24.84

-0.66

(-2.59%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Surgery Partners Inc

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 666.2M → 735.4M (in $), with an average increase of 3.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 35.9M → -1.0M (in $), with an average decrease of 102.8% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 53.9% return, outperforming this stock by 89.4%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 17.1% return, outperforming this stock by 65.5%

Performance

  • $24.56
    $25.47
    $24.84
    downward going graph

    1.13%

    Downside

    Day's Volatility :3.57%

    Upside

    2.47%

    downward going graph
  • $22.05
    $45.79
    $24.84
    downward going graph

    11.23%

    Downside

    52 Weeks Volatility :51.85%

    Upside

    45.75%

    downward going graph

Returns

PeriodSurgery Partners IncSector (Health Care)Index (Russel 2000)
3 Months
-19.48%
1.1%
0.0%
6 Months
11.5%
12.5%
0.0%
1 Year
-35.49%
6.9%
2.2%
3 Years
-48.44%
14.3%
-23.0%

Highlights

Market Capitalization
3.2B
Book Value
$15.79
Earnings Per Share (EPS)
-0.09
PEG Ratio
1.66
Wall Street Target Price
42.36
Profit Margin
-0.43%
Operating Margin TTM
19.84%
Return On Assets TTM
3.83%
Return On Equity TTM
4.07%
Revenue TTM
2.7B
Revenue Per Share TTM
21.84
Quarterly Revenue Growth YOY
4.0%
Gross Profit TTM
574.9M
EBITDA
533.0M
Diluted Eps TTM
-0.09
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.99
EPS Estimate Next Year
1.27
EPS Estimate Current Quarter
0.38
EPS Estimate Next Quarter
0.12

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Surgery Partners Inc(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
14
14
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 70.53%

Current $24.84
Target $42.36

Company Financials

FY18Y/Y Change
Revenue
1.8B
↑ 32.08%
Net Income
-205.7M
↑ 288.23%
Net Profit Margin
-11.61%
↓ 7.66%
FY19Y/Y Change
Revenue
1.8B
↑ 3.38%
Net Income
46.1M
↓ 122.41%
Net Profit Margin
2.52%
↑ 14.13%
FY20Y/Y Change
Revenue
1.9B
↑ 1.57%
Net Income
1.3M
↓ 97.18%
Net Profit Margin
0.07%
↓ 2.45%
FY21Y/Y Change
Revenue
2.2B
↑ 19.62%
Net Income
70.7M
↑ 5338.46%
Net Profit Margin
3.18%
↑ 3.11%
FY22Y/Y Change
Revenue
2.5B
↑ 14.12%
Net Income
87.0M
↑ 23.06%
Net Profit Margin
3.43%
↑ 0.25%
FY23Y/Y Change
Revenue
2.7B
↑ 8.03%
Net Income
-11.9M
↓ 113.68%
Net Profit Margin
-0.43%
↓ 3.86%
Q3 FY22Q/Q Change
Revenue
620.6M
↑ 0.84%
Net Income
5.6M
↓ 63.4%
Net Profit Margin
0.9%
↓ 1.59%
Q4 FY22Q/Q Change
Revenue
707.1M
↑ 13.94%
Net Income
23.3M
↑ 316.07%
Net Profit Margin
3.3%
↑ 2.4%
Q1 FY23Q/Q Change
Revenue
666.2M
↓ 5.78%
Net Income
1.2M
↓ 94.85%
Net Profit Margin
0.18%
↓ 3.12%
Q2 FY23Q/Q Change
Revenue
667.6M
↑ 0.21%
Net Income
18.9M
↑ 1475.0%
Net Profit Margin
2.83%
↑ 2.65%
Q3 FY23Q/Q Change
Revenue
674.1M
↑ 0.97%
Net Income
35.9M
↑ 89.95%
Net Profit Margin
5.33%
↑ 2.5%
Q4 FY23Q/Q Change
Revenue
735.4M
↑ 9.09%
Net Income
-1000.0K
↓ 102.79%
Net Profit Margin
-0.14%
↓ 5.47%
FY18Y/Y Change
Total Assets
4.7B
↑ 1.16%
Total Liabilities
4.7B
↑ 1.16%
FY19Y/Y Change
Total Assets
5.0B
↑ 7.34%
Total Liabilities
5.0B
↑ 7.34%
FY20Y/Y Change
Total Assets
5.4B
↑ 7.85%
Total Liabilities
5.4B
↑ 7.85%
FY21Y/Y Change
Total Assets
6.1B
↑ 13.01%
Total Liabilities
6.1B
↑ 13.01%
FY22Y/Y Change
Total Assets
6.7B
↑ 9.23%
Total Liabilities
6.7B
↑ 9.23%
FY23Y/Y Change
Total Assets
7.0B
↑ 5.04%
Total Liabilities
3.7B
↓ 45.27%
Q3 FY22Q/Q Change
Total Assets
6.5B
↑ 3.89%
Total Liabilities
4.1B
↑ 4.68%
Q4 FY22Q/Q Change
Total Assets
6.7B
↑ 2.23%
Total Liabilities
6.7B
↑ 63.28%
Q1 FY23Q/Q Change
Total Assets
6.6B
↓ 0.58%
Total Liabilities
475.1M
↓ 92.89%
Q2 FY23Q/Q Change
Total Assets
6.6B
↓ 0.34%
Total Liabilities
3.9B
↑ 730.6%
Q3 FY23Q/Q Change
Total Assets
6.8B
↑ 2.41%
Total Liabilities
6.8B
↑ 71.81%
Q4 FY23Q/Q Change
Total Assets
7.0B
↑ 3.53%
Total Liabilities
3.7B
↓ 46.06%
FY18Y/Y Change
Operating Cash Flow
144.6M
↑ 19.56%
Investing Cash Flow
-128.9M
↓ 83.55%
Financing Cash Flow
-6.3M
↓ 100.83%
FY19Y/Y Change
Operating Cash Flow
129.5M
↓ 10.44%
Investing Cash Flow
-85.2M
↓ 33.88%
Financing Cash Flow
-135.9M
↑ 2042.18%
FY20Y/Y Change
Operating Cash Flow
246.9M
↑ 90.66%
Investing Cash Flow
-88.4M
↑ 3.76%
Financing Cash Flow
66.7M
↓ 149.08%
FY21Y/Y Change
Operating Cash Flow
87.1M
↓ 64.72%
Investing Cash Flow
-331.7M
↑ 275.23%
Financing Cash Flow
316.3M
↑ 374.21%
FY22Y/Y Change
Operating Cash Flow
158.8M
↑ 82.32%
Investing Cash Flow
-307.9M
↓ 7.18%
Financing Cash Flow
42.1M
↓ 86.69%
Q3 FY22Q/Q Change
Operating Cash Flow
29.7M
↓ 29.45%
Investing Cash Flow
-54.3M
↓ 59.57%
Financing Cash Flow
-48.0M
↓ 19.06%
Q4 FY22Q/Q Change
Operating Cash Flow
7.2M
↓ 75.76%
Investing Cash Flow
-72.2M
↑ 32.97%
Financing Cash Flow
193.1M
↓ 502.29%
Q1 FY23Q/Q Change
Operating Cash Flow
74.5M
↑ 934.72%
Investing Cash Flow
-70.7M
↓ 2.08%
Financing Cash Flow
-41.2M
↓ 121.34%
Q2 FY23Q/Q Change
Operating Cash Flow
52.1M
↓ 30.07%
Investing Cash Flow
-71.2M
↑ 0.71%
Financing Cash Flow
-49.0M
↑ 18.93%

Technicals Summary

Sell

Neutral

Buy

Surgery Partners Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Surgery Partners Inc
Surgery Partners Inc
-12.64%
11.5%
-35.49%
-48.44%
130.14%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
9.73%
24.61%
-10.36%
-47.15%
-48.2%
Hca Holdings, Inc.
Hca Holdings, Inc.
-2.65%
43.83%
14.73%
59.06%
154.1%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-3.97%
82.3%
37.12%
75.84%
305.2%
Universal Health Services Inc.
Universal Health Services Inc.
-6.72%
35.75%
17.89%
13.8%
25.97%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-1.86%
71.3%
53.87%
17.11%
138.7%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Surgery Partners Inc
Surgery Partners Inc
NA
NA
1.66
0.99
0.04
0.04
NA
15.79
Fresenius Medical Care Ag
Fresenius Medical Care Ag
23.6
23.6
0.39
2.02
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
16.84
16.84
1.44
20.64
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.21
17.21
2.2
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
16.14
16.14
1.87
13.45
0.12
0.05
0.0
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
18.05
18.05
1.16
9.01
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Surgery Partners Inc
Surgery Partners Inc
Buy
$3.2B
130.14%
NA
-0.43%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$12.6B
-48.2%
23.6
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$84.5B
154.1%
16.84
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$9.7B
305.2%
17.21
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.1B
25.97%
16.14
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.7B
138.7%
18.05
5.7%

Institutional Holdings

  • Bain Capital Investors LLC

    39.45%

  • FMR Inc

    14.48%

  • Wellington Management Company LLP

    6.57%

  • Vanguard Group Inc

    5.86%

  • BlackRock Inc

    4.93%

  • ClearBridge Advisors, LLC

    4.36%

Corporate Announcements

  • Surgery Partners Inc Earnings

    Surgery Partners Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

surgery partners is a leading operator of surgical facilities and ancillary services with more than 180 locations nationwide. we provide exceptional integrated healthcare experiences between our providers and patients. our diverse company operates multiple types of healthcare services dedicated to improving the quality of care in a convenient and cost-effective manner. the support of our ancillary services is one of many unique attributes that differentiate us from our competitors. these services are comprised of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, optical services and specialty pharmacy services. our integrated approach to advancing markets allows for flexibility to provide care on an individualized, local market basis. whether entering into a new market with surgical facilities, ancillary services or joint ventures with health systems, or furthering an existing market’s growth potential by focusing on base busines

Organization
Surgery Partners Inc
Employees
10500
CEO
Mr. Wayne Scott DeVeydt
Industry
Health Services

Discover More

FAQs